Previous Section
Review Articles
11. Older adults: should the paradigm shift from standard therapy?
- Author
- Estey EH;
- Institution
- Section of Acute Leukemia and Myelodysplastic Syndrome, Division of Cancer Medicine, MD Anderson Cancer Center, Box 428, 1515 Holcombe Boulevard, Houston, TX 77030, USA. eestey@mdanderson.org
- Journal
- Best Pract Res Clin Haematol. 2008 Mar;21(1):61-6.
- Abstract URL
- Click here to view abstract
12. Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML).
- Author
- Appelbaum FR;
- Institution
- Fred Hutchinson Cancer Research Center, Clinical Research Division, 1100 Fairview Avenue North, D5-310, P.O. Box 19024, Seattle, WA 98109-1024, USA. fappelba@fhcrc.org
- Journal
- Best Pract Res Clin Haematol. 2008 Mar;21(1):85-92.
- Abstract URL
- Click here to view abstract
13. Gemtuzumab ozogamicin: an anti-CD33 immunoconjugate for the treatment of acute myeloid leukaemia.
- Author
- Stasi R;
- Institution
- Regina Apostolorum Hospital, Department of Medical Sciences, Via S. Francesco, 50, 00041 Albano Laziale, Italy. roberto.stasi@uniroma2.it
- Journal
- Expert Opin Biol Ther. 2008 Apr;8(4):527-40.
- Abstract URL
- Click here to view abstract
14. Hematopoietic stem cell transplantation in adults with acute myeloid leukemia.
- Author
- Hamadani M; Awan FT; Copelan EA;
- Institution
- Division of Hematology & Oncology, Arthur G. James Cancer Hospital, Ohio State University, Columbus, Ohio, USA.
- Journal
- Biol Blood Marrow Transplant. 2008 May;14(5):556-67.
- Abstract URL
- Click here to view abstract
15. Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.
- Author
- Lekakis L; de Lima M;
- Institution
- Department of Hematology, Medical Oncology & Blood and Marrow Transplantation, Markey Cancer Center, University of Kentucky, 800 Rose St, Roach Building, Ste 412, Lexington, KY 40536, USA. ljleka2@uky.edu
- Journal
- Expert Rev Anticancer Ther. 2008 May;8(5):785-98.
- Abstract URL
- Click here to view abstract
16. Potential role of novel nucleoside analogs in the treatment of acute myeloid leukemia.
- Author
- Faderl S; Gandhi V; Kantarjian HM;
- Institution
- Department of Leukemia, Unit 428, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. sfaderl@mdanderson.org
- Journal
- Curr Opin Hematol. 2008 Mar;15(2):101-7.
- Abstract URL
- Click here to view abstract
17. Integration of monoclonal antibodies and immunoconjugates into the treatment of acute myeloid leukemia.
- Author
- Amadori S; Stasi R;
- Institution
- Department of Hematology, Tor Vergata University Hospital, Rome, Italy. sergio.amadori@ptvonline.it
- Journal
- Curr Opin Hematol. 2008 Mar;15(2):95-100.
- Abstract URL
- Click here to view abstract
18. New molecular concepts and targets in acute myeloid leukemia.
- Author
- Buzzai M; Licht JD;
- Institution
- Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.
- Journal
- Curr Opin Hematol. 2008 Mar;15(2):82-7.
- Abstract URL
- Click here to view abstract
19. Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation.
- Author
- Loren AW; Porter DL;
- Institution
- Bone Marrow and Stem Cell Transplant Program, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA 19104, USA. alison.loren@uphs.upenn.edu
- Journal
- Bone Marrow Transplant. 2008 Mar;41(5):483-93. Epub 2007 Nov 19.
- Abstract URL
- Click here to view abstract
20. Gemtuzumab ozogamicin (mylotarg) for the treatment of acute myeloid leukemia--ongoing trials.
- Author
- Gleissner B; Schlenk R; Bornhauser M; Berdel WE;
- Institution
- Department of Medicine I, University Hospital Saarland, Homburg, Germany. beate.gleissner@uniklinikum-saarland.de
- Journal
- Onkologie. 2007 Dec;30(12):657-62. Epub 2007 Nov 30.
- Abstract URL
- Click here to view abstract
